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Chronic somatoform pain is a frequently occurring disorder that can induce extensive distress, 37 
impairment, and disability [1]. Multimodal interdisciplinary treatment represents the treatment of 38 
choice [2]; it typically combines psychotherapy, physical therapy and medical interventions [3]. 39 
In other words, psychotherapy is a central component within a multimodal interdisciplinary 40 
treatment setting [3] and it is also considered to be effective for the treatment of chronic pain [4]. 41 
Motivation for psychotherapy has been defined as a construct encompassing components of 42 
negative illness consequences, psychosocial lay etiology, positive psychotherapeutic treatment 43 
expectations and a general openness to psychotherapy [5]. According to the IMMPACT 44 
recommendations, core effectiveness outcomes of chronic pain treatment include pain intensity, 45 
global rating of improvement, physical functioning and emotional functioning [6]. Means to 46 
fulfill some of these requirements are numerical rating scales (NRS) to measure pain intensity 47 
and depressive symptom scales to assess emotional functioning [7]. Whereas the importance of 48 
psychotherapy motivation for treatment outcomes has been shown for domains such as 49 
somatization syndrome [8], to our knowledge, as yet, no studies have tested prognostic effects of 50 
psychotherapy motivation on outcomes of multimodal interdisciplinary treatment for chronic 51 
somatoform pain.  52 
The novelty and aim of this study were to investigate the predictive value of initial 53 
psychotherapy motivation on outcomes of multimodal interdisciplinary treatment of chronic 54 
somatoform pain. We specifically hypothesized that higher levels of psychotherapy motivation 55 
assessed before treatment would be associated with greater reductions in pain intensity (primary 56 
outcome) and psychological distress, including depressive symptoms (secondary outcomes), all 57 
independent of age, gender, illness duration and initial levels of outcome measures. 58 
Between 2011 and 2014, we collected data from 403 consecutive inpatients with chronic 59 
somatoform pain at the beginning and at the end of a multimodal interdisciplinary treatment 60 
program at a tertiary psychosomatic university clinic in Switzerland. The inpatient treatment 61 
program included medical interventions, pharmacotherapy, psychotherapy, relaxation, and 62 
physical therapy. All participants provided informed consent for the use of their anonymized 63 
health data for research purposes. The study was conducted in accordance with applicable Swiss 64 
research legislation. All patients completed a set of standardized self-report assessment tools, 65 
which were the Questionnaire for the Measurement of Psychotherapy Motivation [5], an 11-point 66 
numeric rating scale for the mean pain intensity over the last week (NRS, range 0-10), the Beck 67 
Depression Inventory [7], and the Brief Symptom Inventory to assess general psychological 68 
distress [9]. In the current study, Cronbach’s alpha yielded acceptable to excellent internal 69 
consistency for the applied scales. Missing data were replaced using multiple imputation. Socio-70 
demographic data were complete. 71 
On average, patients were 48.9 years old (SD = 13.2; range 18–89) and 54.1% (n = 218) were 72 
women. The average duration of inpatient treatment was 28.8 days (SD = 7.7, range 10–71). 73 
Whereas psychotherapy motivation at pretreatment correlated significantly with symptoms of 74 
depression (r = 0.36, p < 0.001) and global psychological distress (r = 0.40, p < 0.001), it did not 75 
with mean pain intensity (r = -0.04, n.s.). 76 
The primary outcome, mean pain intensity (NRS), decreased significantly from pre- to post-77 
treatment (6.6±1.9 vs. 5.6±2.1; p < 0.001; Cohen’s d = 0.51). The secondary outcome, mean 78 
level of depressive symptoms (BDI), decreased significantly from pre- to post-treatment 79 
(19.3±10.1 vs. 15.0±10.0; p < 0.001; Cohen's d = 0.58). These symptom reductions roughly 80 
correspond to clinically important improvement (see IMMPACT benchmarks, [6]) of a medium 81 
effect size. In addition, global psychological distress (BSI) decreased significantly from pre- to 82 
post-treatment (1.0±0.6 vs. 0.8±0.6; p < 0.001; Cohen's d = 0.45). 83 
To test the prediction of treatment outcome by initial psychotherapy motivation, we used 84 
separate hierarchical regression analyses for all outcome variables (Table 1). For all analyses, 85 
age, gender, illness duration and initial levels of outcome variables were entered as control 86 
variables in one block. Psychotherapy motivation was entered in the second and final block, and 87 
uniquely accounted for 2% of the variance in mean pain intensity, 1% in symptoms of depression 88 
and 2% in global psychological distress at posttreatment, above and beyond effects of the control 89 
variables. In the final model, greater pretreatment psychotherapy motivation was predictive of 90 
lower levels of posttreatment pain intensity ( = -0.14, t = -2.79, p < 0.01), depressive symptoms 91 
( = -0.12, t = -2.37, p < 0.05), and global psychological distress ( = -0.14, t = -2.78, p < 0.01). 92 
In sum, our study showed statistically significant reductions in relevant primary (pain intensity) 93 
and secondary (emotional functioning) outcomes following inpatient multimodal 94 
interdisciplinary pain treatment. Notably, patients high in initial psychotherapy motivation 95 
showed greater treatment benefits compared with less motivated patients. 96 
Psychotherapy motivation appears to be an important predictor of posttreatment pain intensity 97 
and emotional wellbeing in multimodal interdisciplinary treatment of chronic somatoform pain 98 
in hospitalized patients. The findings from our study may inform interventions targeting the 99 
improvement of patients’ motivation for psychotherapy to test their potential for enhancing the 100 
effectiveness of multimodal pain treatment. Potential targets of such interventions are 101 
“psychological-mindedness” regarding illness perception, positive treatment expectations and 102 
openness for psychological interventions. Initial treatment motivation may also serve as a useful 103 
criterion for determining differential treatment selection within an individually tailored treatment 104 
program.  105 
The present study has important limitations. The potential for socially desirable response 106 
tendencies of chronic pain patients when completing self-report measurements should be taken 107 
into consideration. Since the multimodal treatment program is provided by a number of 108 
therapists from different disciplines, the assessment of therapist effects did not seem feasible in 109 
this setting. Future research could, for example, employ daily assessments to test more 110 
immediate therapist effects that may contribute to the overall outcome. The lack of long-term 111 
follow-up data limits interpretation as to whether the observed associations persist beyond 112 
hospitalization. Thus, future studies could benefit from longitudinal designs to test for 113 
sustainable effects of psychotherapy motivation on treatment outcomes. 114 
Our study implicates that clinicians may want to pay special attention to chronic somatoform 115 
pain patients’ motivation for psychotherapy. Whether interventions targeting psychotherapy 116 
motivation may indeed improve treatment outcome in these patients awaits further studies.  117 
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